Showing posts with label Nebraska. Show all posts
Showing posts with label Nebraska. Show all posts

Sunday, May 22, 2011

Nebraska moving to conduct its first execution since 1997

The US state of Nebraska is moving to conduct its first execution since 1997. An execution date of 14 June has been set for Carey Dean Moore, who has been on death row for three decades.

Carey Dean Moore was re-sentenced to death in 1995 after his original 1980 sentence was overturned on appeal. He was one of more than 300 people sentenced to death in 1995. Indeed, in 1994, 1995 and 1996, over 300 people were sentenced to death each year in the USA, the most recorded in any years since executions resumed in 1977. In the past decade one of the signs that the USA is beginning to turn against the death penalty is that the number of death sentences passed each year has substantially declined. Since 2006 just over 100 people have been sentenced to death each year. The annual number of executions peaked at 98 in 1999, and has since fallen to around half that number each year. The last execution in Nebraska was in December 1997.

In the past four years, three states – New Jersey, New Mexico and Illinois – have legislated to abolish the death penalty. Signing these bills into law, the three state governors pointed to the death penalty’s flaws, such as the risk of irrevocable error and unfairness, its discriminatory application, its costs and diversion of resources from crime prevention and victim assistance, the lack of any proven special deterrent effect, and its potentially brutalizing effect on society. In 2008, the then most senior member of the US Supreme Court, Justice John Paul Stevens, revealed that his 33 years on the Court had persuaded him that the “imposition of the death penalty represents the pointless and needless extinction of life”. In the 14 years since Nebraska last carried out an execution, some three dozen more countries have abolished the death penalty, and today 139 countries are abolitionist in law or practice. The UN General Assembly has called on all retentionist countries to impose a moratorium on executions. During scrutiny of the USA’s human rights record under the UN Human Rights Council’s Universal Periodic Review Process in late 2010, numerous countries called on the USA to end its use of the death penalty.

Carey Dean Moore, who was 21 years old at the time of the crime and is now 53, is not currently seeking executive clemency. While there is therefore no clemency petition before these authorities, Amnesty International nevertheless is urging them to act to prevent Nebraska from taking the backward step of carrying out its first execution in 14 years. Carey Dean Moore is allowing his lawyers to seek a stay of execution in the courts in the context of issues relating to lethal injection, including the state’s recent purchase of drugs from a company in India.
Additional Information

Recommended action

PLEASE WRITE IMMEDIATELY in English or your own language, in your own words:

Expressing concern that the State of Nebraska is looking to conduct its first execution in 14 years;
Welcoming the growing recognition in the USA of the inherent flaws of the death penalty;
Welcoming the recent abolition of the death penalty in Illinois, New Mexico and New Jersey;
Noting the growing isolation of the USA on the death penalty, and the international calls for a worldwide moratorium on executions;
Urging the authorities to do all they can to prevent any executions in Nebraska, including of Carey Dean Moore.

Please note that as Carey Dean Moore is not currently seeking executive clemency, we are not calling for commutation of his death sentence, as there is no clemency petition before the state executive authorities. However, given our abolitionist policy and the backward step that we consider an execution in Nebraska would constitute, we should still urge these authorities to do all they can to prevent any executions in Nebraska, including that of Carey Dean Moore.

PLEASE SEND APPEALS AS SOON AS POSSIBLE, AND BEFORE 14 JUNE 2011.

Appeals to

Secretary of State John A. Gale,
PO Box 94608,
Lincoln,
NE 68509-4608,
USA.
Fax: +1 402 471-3237 // 471-3237
Salutation: Dear Secretary of State

Attorney General Jon Bruning,
Office of the Attorney General,
2115 State Capitol,
Lincoln,
NE 68509,
USA.
Fax: +1 402 471-3297
Salutation: Dear Attorney General

Copies to

Governor Dave Heineman,
Office of the Governor,
PO Box 94848,
Lincoln,
NE 68509-4848,
USA.
Fax: +1 402-471-6031
Salutation: Dear Governor

Ambassade des Etats-Unis d'Amérique,
Sulgeneckstrasse 19,
Case postale,
3007 Berne.
Fax : 031 357 73 44 // 031 357 73 98
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Wednesday, May 18, 2011

Death row lawyers question competence of lethal injection drug supplier

Lawyers for a US death row prisoner have called for his execution not to go ahead due to serious questions over how the drugs set to be used were imported, and the competence and credibility of their supplier.

A motion filed by Carey Dean Moore’s lawyers in Nebraska asserts that the state’s Department of Correctional Services (DCS) did not obtain the execution drug sodium thiopental from a manufacturer approved by the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA).

It also questions whether the drug supplier's personnel “have the level of competence, professionalism and credibility to be DCS’ source of one of the essential lethal drugs”, in the light of abusive emails between the firm’s director and other staff following an internal dispute.

The Director of India-based Kayem Pharma, which supplied the sodium thiopental, has described his former US colleagues who were in direct contact with Nebraska’s DCS as “drug peddlers” in emails to Moore’s lawyers. Kayem’s former US personnel have sent the Director emails referring to him as a “piece of shit thief”.

Reprieve Investigator Sophie Walker said:

“It is hard to see how Nebraska’s department of corrections can defend the use of these drugs in executions.

“Not only were they improperly imported – but they were bought by Nebraska from people described as ‘drug peddlers’ by one of their own colleagues.

“The revelation of chaotic and abusive relations between Kayem Pharma’s US and Indian personnel casts serious doubt over their competence.

“If Nebraska now pushes ahead with executions using these drugs, it risks irreparably damaging its credibility.”

Source: Reprieve, May 18, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Thursday, May 5, 2011

Pending U.S. Executions (as of 05/06/11)

Please note that these dates are only tentative.

Execution dates known or thought to be considered SERIOUS are marked with a *.The designation indicates that an execution is considered more likely to be carried out.

Please note that this designation should in no way be construed as absolute. Stays can be granted or denied at the very last moment prior to an execution.

A name with no * designation may simply mean that not enough information is currently available to know whether the execution date is serious. In other words, please DO NOT automatically equate the fact that a name with no * designation means that his/her assigned execution date is not serious. It might, in fact, be (very) serious.

2011

May

6* Jeffrey Motts, South Carolina

10* Benny Joe Stevens, Mississippi

17* Daniel Bedford, Ohio

17* Rodney Gray, Mississippi

19* Jason Williams, Alabama

25* Donald Beaty, Arizona

June

1* Gayland Bradford, Texas

14* Shawn Hawkins, Ohio

14* Carey Dean Moore, Nebraska

15* John Balentine, Texas

16* Lee Andrew Taylor, Texas

16* Eddie Powell, Alabama

21* Milton Mathis, Texas

22* Frank Williams Jr., Arkansas

July

7* Humberto Leal, Texas

12* Marcel Williams, Arkansas

19* Kenneth Smith, Ohio

20* Mark Stroman, Texas

August

10* Martin Robles, Texas

16* Brett Hartman, Ohio

30* Ivan Cantu, Texas

September

13 Joel Schmeiderer, Tennessee

15* Duane Buck, Texas

20* Billy Slagle, Ohio

27 David Jordan, Tennessee

October

4 John Henretta, Tennessee

11 H-R Hester, Tennessee

18* Joseph Murphy, Ohio

November

15* Reginald Brooks, Ohio


2012

January

18* Charles Lorraine, Ohio

February

22* Michael Webb, Ohio


Click here for additional information on scheduled executions in Texas on the TDCJ website.
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Friday, April 22, 2011

Death-row lawyer: Nebraska bought lethal-injection drug from rogue broker

Kayem Pharma Mumbai office entrance
Source: Reprieve More here
The Nebraska Supreme Court late Thursday rejected a complex appeal by death-row inmate Carey Dean Moore and ordered him to be executed on June 14.

In doing so, the court rejected arguments by Moore's lawyers challenging the legality of Nebraska's purchase from an Indian company of 1 of 3 drugs used in the state's lethal-injection protocol and questioning whether the state even bought the right drug.

Jerry Soucie, a lawyer with the Nebraska Commission on Public Advocacy, had asked the court to order a lower court to hear the issue of the state's purchase.

"The subject matter of the proceeding pending herein is not one which the Nebraska Supreme Court may ‘remand' to a district court," Chief Justice Michael Heavican wrote.

Soucie declined immediate comment.

Meanwhile, court documents filed earlier Thursday said the state might have bought the lethal injection drug from a rogue pharmacy broker who just wanted to make quick money.

The state paid $2,056 to Kayem Pharmaceutical Pvt. Ltd. for 500 grams of sodium thiopental. The drug has been in short supply since last year and the only U.S. manufacturer, Hospira Inc., is ending production because of death-penalty opposition overseas.

But in an email this week to Soucie, the CEO of Kayem said the state bought the drug from a pharmacy broker who deceived the company -- even going as far as registering it to do business in Nevada without its knowledge.

CEO Navneet Verma said an Indian citizen named Chris Harris approached his company last year about being a pharmacy broker for Kayem.

Harris later allegedly told Verma he and another man, Tony Atwater of Steuben, Maine, already had registered the company as a corporation in Nevada under the name Kayem Pharmaceutical LLC.

"This sudden and abrupt formation of a company by this duo has given rise to suspicion about ... deceit by the hands of this duo," Verma said. "... The intention of this duo was clear to us as they wanted to make quick money ... getting themselves in the unethical practices ... detrimental to Kayem Pharmaceutical."

Verma said the sale of the drug was between Harris and Steve Urosevich, chief operating officer for the Nebraska Department of Correctional Services.

He said Kayem simply supplied the drug to Harris. Verma also said the company since has cut ties with Harris.

"The inescapable conclusion is that Chris Harris and Kayem are rogue foreign pharmaceutical brokers/distributors and that the importation of a controlled substance by DCS was in violation of the applicable federal statutes," Soucie wrote in court filings.

Soucie says the address listed by Harris with the Nevada Secretary of State's office is that of a mail forwarding service called "Mostly Mail," which advertises mail boxes for rent.

Harris did not immediately respond to an email request seeking comment.

Atwater said Verma approved of their registering Kayem in Nevada, but the 2 had a subsequent falling out over money and parted ways.

Kayem completed a federal "Certificate of Origin" dated Dec. 8, 2010, that said the drug shipped to the Nebraska Department of Correctional Services was "Thiopentone ... thiosol sodium" manufactured by Neon Laboratories Ltd. of Mumbai, India.

The state's lethal injection protocol calls for using "sodium thiopental." It appears, Soucie said, that the state might have bought a generic version.

"The state's own attachment to the motion for an execution date does NOT allow for the use of ‘thiopentone' or ‘thiosol sodium' as the first of the drugs in the lethal execution cocktail," Soucie said in a motion to the high court asking for a hearing.

He said federal law requires that before a new drug is used in the United States, the manufacturer must file an application with the Food and Drug Administration outlining the drug's safety, composition and manufacturing process, among other things.

To market a generic drug in the United States, a manufacturer must file an application showing the FDA has approved its active ingredients.

Verma said his company is not so licensed. Nor, he said, is Kayem or Neon Laboratories registered with the Drug Enforcement Administration and authorized to deliver controlled substances to the United States.

Soucie said the DEA registration held by the Corrections Department does not authorize it to directly import drugs from a foreign supplier.

The DEA recently seized Georgia's entire supply of sodium thiopental, which defense attorneys say came from a questionable British supplier. The DEA said there were questions about how it was imported.

FDA spokeswoman Shelly Burgess has said the agency could not comment on the Nebraska case. The DEA referred inquiries to the U.S. Department of Justice, which also has declined comment.

Nebraska corrections officials deferred comment to state Attorney General Jon Bruning's office. Said Bruning: "The court order speaks for itself."

In court papers, the attorney general's office said Soucie should not be allowed to ask for a hearing since the high court had been asked to set an execution date for Moore.

In his filing, Soucie wrote, "without evidence of compliance with these federal regulatory requirements, there is no basis upon which to presume the efficacy of these specific drugs obtained from Kayem and that they do not present a ‘substantial' or ‘objectively intolerable risk of harm' during a judicial execution."

According to documents reviewed by the Journal Star, the corrections department paid Phil Patterson Inc., an import company based in Omaha, to facilitate shipment of the drug from India.

Kayem issued the certificate of origin for the drug and the shipment was under the supervision of customs officials in India and the United States, said Megan Cooley, who oversaw the importation for Phil Patterson Inc.

Once the shipment arrived in the United States, it was tested by Medtox Laboratories in St. Paul, Minn., to verify that it was sodium thiopental, according to the documents.

Soucie also questions the legitimacy of Kayem to make a lethal injection drug.

He said Kayem's main facility in India is in a ground-floor apartment in Mumbai.

"There are 2 small rooms, one serving as an office and the other as a storage room," Soucie said. "There is no air conditioning or climate control at this building.

"Kayem Pharmaceuticals does not appear to be involved in the direct formulation of any medications with the exception of Indian herbal remedies to alleviate symptoms of arthritis, upper respiratory infections, constipation, hemorrhoids and inadequate male sexual performance," Soucie said. "Kayem's primary business activity appears to be the production of tablets, capsules, ointments and injectable products as a subcontractor for other generic drug companies located in India."

A federal lawsuit has been filed in Arizona challenging the use of the drugs from overseas suppliers, saying they may be substandard and could lead to problems during executions.

As for the drug Nebraska got, Atwater said it is the real thing.

"It's all legal," he said.

The Nebraska Legislature approved lethal injection as the state's method of execution in May 2009.

Moore, 53, has been on death row since 1980. He was sentenced to die for killing Omaha cab drivers Maynard D. Helgeland and Reuel Eugene Van Ness during botched robberies in 1979.

The state has not executed an inmate since Robert Williams died in the electric chair in 1997.


Source: Lincoln Journal Star, April 22, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Saturday, April 16, 2011

Pennsylvania House Votes to Expand Death Penalty as International Controversy Mounts

Pennsylvania's moves in the opposite direction of the prevailing winds of reform.

On April 6, Sister Helen Prejean, author of the book "Dead Man Walking" and the inspiration for the 1995 film of the same name starring Susan Sarandon as a Catholic nun counseling a condemned prisoner, stood before a packed crowd at Chestnut Hill College in Philadelphia to tell her story and urge attendees -- especially young people -- to join efforts to end capital punishment in Pennsylvania.

"As long as we are not active, as long as we don't raise our voice, as long as we don't resist, we too are responsible," said the fiery, 71 year-old abolitionist.

Her talk couldn't have come at a more dubious time for the death penalty in America.

Since Governor Pat Quinn formally abolished capital punishment in Illinois in March, legislators in no less than half-a-dozen states have introduced bills to repeal the death penalty and replace it with life without parole. States where abolitionist legislation is being considered include three of the death penalty's "big four" -- Texas, Florida and Pennsylvania, which together account for nearly a third of the nation's condemned inmates. (California, which leads the nation with 711 prisoners awaiting execution, has no such legislation pending).

Separately, an international scandal involving a key ingredient used to execute inmates has focused world attention on a U.S. practice that remains out of step with much of the developed world.

Earlier this year Illinois-based Hospira, the only American-based manufacturer of the barbiturate sodium thiopental, chose to stop making it rather than promise authorities in Italy - the site of its new manufacturing facility - that its drug wouldn't be used for capital punishment. Until recently sodium thiopental, sold under the brand name Pentothal, was a primary ingredient in the lethal injection cocktails of 34 states.

Hospira was already facing a shortage of key components used in the manufacture of the drug. The decision to cease production sparked a nationwide shortage of sodium thiopental and forced some states to seek the drug from less reputable overseas suppliers, sparking controversy and in some cases legal intervention.

On March 15 the Drug Enforcement Agency seized Georgia's entire stock of sodium thiopental less than a month after attorneys for inmate Andrew Grant DeYoung notified Attorney General Eric Holder that the Georgia Department of Corrections had imported a quantity of the drug without proper registration from the United Kingdom last July. Since December 2011 Britain has enforced export controls on sodium thiopental.

According to records obtained by attorney John Bentivoglio, the drug came from a small, mom-and-pop wholesaler called Dream Pharma, which ran its operations out of a rented space in the back of a driving school in Acton.

Georgia had already executed two men using the drug, both of whom kept their eyes open during the process. An analysis by the UK-based death penalty abolitionist group Reprieve suggests the quality of the sodium thiopental may have been compromised by poor storage, and both inmates were likely partially conscious throughout the execution process -- a grueling experience according to anesthesiologists .

"At last someone is paying attention to the shenanigans that have been going on with the fly-by-night company exporting large quantities of execution drugs from Britain," said Reprieve's Director Clive Stafford Smith, commenting on the DEA's action.

Kentucky and Tennessee responded to the seizure by turning over their entire stocks of sodium thiopental to federal authorities, but at least 5 other states are reported to have acquired the drug overseas. Last week The Times of India revealed that at least 2 states, Nebraska and South Dakota, were using a Mumbai-based company as their supplier; on April 6, the company, Kayem Pharmaceutical, said it would no longer ship the drug to the U.S.

Pennsylvania - where more than 200 condemned inmates sit on death row -- has so far refrained from entering the debate, and no published reports exist outlining its plans as sodium thiopental becomes less available.

Susan McNaughton, communications director at the Pennsylvania Department of Corrections, declined to comment on the supplier of the state's sodium thiopental, or if it maintained a stock of the drug, but said the DOC is "reviewing its options" as to how the issue surrounding the availability of the drug will affect the execution process in Pennsylvania, if at all.

"We have no reason to think that we are not prepared to carry out executions," she said.

A request under Pennsylvania's Right to Know Law for information on who supplies Pennsylvania's execution drugs, whether or not they are stockpiled and how often the stocks are rotated was pending at press time.

The fact that the state hasn't hosted an execution in more than a decade certainly makes the situation seem less than urgent. However, according to the drug's guidelines, the average shelf life for sodium thiopental is 4 years, meaning the state would need to rotate stocks at least that frequently, or would need to order it before an execution proceeds.

Seeking to circumvent the controversy, some prisons have decided to abandon sodium thiopental altogether. Last month Ohio became the first state to execute an inmate with a single dose of pentobarbital - a short-acting barbiturate commonly used to euthanize animals -- while several others states have said they will begin using pentobarbital in place of sodium thiopental as 1 of 3 execution drugs. That decision is already raising challenges from defense attorneys who say the new drug is unproven and that some states, Texas for instance, have not followed the correct protocol for making such a change.

Meanwhile, many European governments have stepped up efforts to ensure they are not complicit in a practice they oppose. On April 1, Germany petitioned the European Union to consider banning sodium thiopental for exportation to countries where it could be used for execution, and legislators in the UK are lobbying the government to add the other 2 drugs commonly used in lethal injections -- potassium chloride and pancuronium bromide -- to the country's list of banned exports. Given European sentiment concerning capital punishment, pentobarbital may one day face the same fate. With as much as 40 % of pharmaceuticals now being made outside the United States, the implications could be reaching.

Death penalty opponents say the international outcry underscores just how isolated the U.S. is from its allies on the issue of capital punishment.

"This is a sign that it's difficult to do the business of killing people when there are others out there who don't want to participate," said Andy Hoover, Legislative Director of the Pennsylvania American Civil Liberties Union.

PA Legislators push alternate death penalty bills

The day before Sister Prejean visited Chestnut Hill, the Pennsylvania House of Representatives unanimously voted to approve a bill that -- if it passes the GOP-controlled Senate -- could see more inmates sent to death row in the Keystone State.

The legislation -- House Bill 317 -- adds two new aggravating factors to the 18 already considered when determining if the death penalty applies to defendants in murder cases, making capital punishment applicable for defendants that commit sexually violent murder while they are registered sex offenders, as well as those who target the elderly and infirm.

"The House is just completely out of step with reality," said Hoover, commenting on the bill. "They are refusing to accept that this is a broken program. The death penalty was made to be used in limited circumstances, but by adding a category for people that are infirm, which lacks definition, the House is expanding it to where it can be applied to most homicides."

The bill's sponsor, Rep. Kerry Benninghoff, a Republican representing parts of Centre and Mifflin Counties, didn't respond to calls and e-mails seeking comment, but in a statement he said the bill is about "justice, protecting law-abiding citizens and keeping dangerous people off the streets."

Two Democratic senators -- Allegheny County progressive Jim Ferlo, and Daylin Leach -- who represents parts of Delaware and Montgomery Counties -- are seeking to end capital punishment in the Commonwealth.

According to Leach, who in February introduced a bill to place a statewide moratorium on executions, the cost of putting people on Death Row where they'll sit for years through endless appeals just doesn't make any sense given the budget crisis currently facing the state. Studies show it costs more than twice as much in appeals, administration and housing to put an inmate to death than to house him or her for the rest of their lives, while polls show waning support across the nation for the death penalty. The most recent numbers in Pennsylvania show that less than half of respondents favor the death penalty when given the alternative option if life without parole.

"The Death Penalty is just another government program that is too expensive and just not working," said Leach, in an appeal to his conservative colleagues.

Since Pennsylvania reinstated the death penalty in 1977, only three executions have been carried out (the last a dozen years ago), and in all three cases the defendants waved their appeals. It's been nearly half a century since the state executed someone who didn't ask to be. Since then at least 20 condemned inmates have died of natural causes.

Nonetheless, Pennsylvania governors from both parties continue to sign dozens of death warrants, making Pennsylvania's Death Row the fourth largest in the nation. Governor Ed Rendell, a Democrat, signed 119 death warrants during his tenure; and newly minted Republican Governor Tom Corbett has already signed four since taking office in January. There are currently 222 inmates awaiting their execution date, more than half of them Black men from Philadelphia County.

Philadelphia District Attorney Seth Williams supports the death penalty but has said he will use it more conservatively than his predecessor Lynn Abraham, who gained a reputation for aggressively pursuing capital murder charges.

According to Tasha Jamerson, a spokesperson for Williams, the DA's office has filed 11 capital cases since Williams took office, and Jamerson reports a "steady decrease in capital prosecutions since 2003."

The American Bar Association has a theory as to why the Keystone State carries out so few executions despite having so many condemned: Pennsylvania is the only state in the nation that provides no post-conviction financial support for defense appeals, meaning defendants are often required to turn to county services and the aid of less-than-able court-appointed attorneys. As a result, cases are often wildly mismanaged, and regularly overturned on appeal at the expense of taxpayers.

Since 1980, more than 200 death sentences in Pennsylvania have been overturned by federal and state courts, and nearly as many death convictions are vacated in Pennsylvania each year as are handed down.

As states across the country rethink their stance on capital punishment, it's fallen to a handful of "true believers" -like Florida, Texas and Ohio to conduct the majority of America's executions. How long Pennsylvania will continue to count itself among this group remains to be seen, but advocates are confident it's not a matter of if, but when the state will abolish capital punishment.

"It might not be on the first try, it might not be on the second try, but if people keep the pressure on eventually we can change this," said Prejean. "Politicians do eventually listen to the people."

A coalition of 15 statewide abolitionist groups, including Pennsylvanians for Alternatives to the Death Penalty (PADP), The Interfaith Alliance of Pennsylvania, Murder Victims' Families for Human Rights, and the ACLU of Pennsylvania is working hard to see that that they do.

"I think with many changes, it's a question of chipping away, little by little and day by day," said Kathleen Lucas, executive director for PADP. "We will get there. Once our legislators see how broken the system is, I believe that they'll do the right thing. The evidence is on our side."

Source: alternet.org, April 16, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Friday, April 8, 2011

Merchants of death

An execution-frenzy may have been unleashed among death penalty U.S. States with execution drugs successfully sourced from India's Kayem Pharma Company. Will Indian authorities now tacitly condone the entry of generic drug manufacturers into a bloodthirsty niche of global commerce?

Brandon Rhode (31) was not in good shape when he was strapped into the execution chamber gurney on September 27 2010, in Georgia, United States. Six days earlier he had attempted suicide because, according to court documents, he did not want to be “put down like a dog.” As a result, he was left with “deep gaping wounds” from the razor he used to slash his neck and elbows. He was also said to have been brain-damaged from sheer blood loss.

Unfortunately for Rhode, convicted in 2000 of killing three persons during a burglary attempt, the worst was yet to come. For although medics spent 30 minutes trying to find a vein in Rhode's arm, into which they could insert needles to administer lethal drugs, something was clearly going wrong when the drugs started pumping. The first drug injected into Rhode, sodium thiopental, was supposed to render him unconscious, yet Rhode's eyes remained open throughout the procedure and moments before he was pronounced dead he was said to have turned his head and exposed the bandage over his slashed neck.

In a sworn declaration Mark Heath, a medical doctor and an expert witness in lethal injection cases, said: “Given the highly unusual provenance of the thiopental that was used in the Rhode execution, one explanation for the eyes remaining open is that the thiopental lacked efficiency.”

The “unusual provenance” that Dr. Heath mentioned in his report was a reference to the fact that the Georgia Department of Corrections (DOC) had imported the thiopental from Dream Pharma, a company located in the United Kingdom, “which operates out of the back of a driving school in London,” according to Dr. Heath.

Why did a key death penalty State of the U.S., itself a country steeped in a long and contentious history of capital punishment, have to resort to importing a lethal injection drug? A little bit of background is in order here, especially because since January execution drugs have entered the U.S. from yet another “unusual provenance” — Kayem Pharma Company of Mumbai, India.

While the history of the lethal injection goes back to May 1977, when the Oklahoma legislature first adopted it as a statute-supported method of execution, today 37 of the 38 death penalty States have lethal injection statutes. However, the entire execution “industry” in the U.S. relied on only one company for the supply of the lethal drugs cocktail — a firm called Hospira located in Lake Forest, Illinois. Emails, obtained by The Hindu, between Hospira and the Nebraska DOC, importer of thiopental from Kayem Pharma, made it clear that Hospira “do not support the use of any of our products in capital punishment procedures.”

Matters took a turn for the worse for States such as Nebraska when Hospira announced in the summer of 2010 that it had temporarily ceased production of thiopental due to a “shortage of raw materials.” Yet, according to Clive Stafford Smith, Director of a U.K.-based anti-death-penalty campaign group called Reprieve, the reason for the stoppage was that Hospira's plant was old and re-tooling it would be uneconomical given that thiopental is now off-patent.

Italy's stance

When Hospira sought to supply thiopental from a plant it owned in Italy, Reprieve campaigners worked with the Italian government, which was said to have been “shocked that Italy might be involved in the execution business,” and eventually “suggested to Hospira Italy that if they exported any drugs used for executions they might end up losing their export licence altogether.” At this point, according to Mr. Smith, Hospira made the “sensible decision” to cease production of the drugs altogether.

With the supplies of thiopental dwindling rapidly around the U.S., death penalty States saw themselves faced with two options. First, some of them, such as Ohio, Arizona, Oklahoma and Texas, switched to another anaesthetic, pentobarbital, commonly used for euthanising animals, and whose effects on human beings for execution purposes has never been tested.

States such as Ohio and Oklahoma have already executed four prisoners using pentobarbital, despite anaesthesia specialists such as David Waisel of Harvard Medical School warning that “the use of pentobarbital as an agent to induce anaesthesia has no clinical history... [and] puts the inmate at risk for serious undue pain and suffering.”

Act of desperation

In what might well have been an act of desperation, State executioners then decided to start importing thiopental, in the first instance from Dream Pharma in the U.K. Scarcely imagining the enormity of the legal backlash that would ensue, Arizona led the way, quickly executing Jeffrey Landrigan on October 25 2010 using the British thiopental. Georgia followed suit, executing Emmanuel Hammond on January 25 2011, having already executed Rhode.

The instant it was revealed in the British media that a home-grown company was supplying lethal drugs for U.S. executions, there was a flurry of public and legal campaigns mostly targeting two Liberal Democrats, Business Secretary Vince Cable and Foreign and Commonwealth Office Minister of State Jeremy Browne.

They initially declined to intervene; however they reversed that decision, reportedly after seeing evidence that the drug was only being exported for use on death row. Mr. Cable said: “In light of new information I have taken the decision to control the export of sodium thiopental. This move underlines this government's and my own personal moral opposition to the death penalty in all circumstances without impacting legitimate trade.”

The Kayem deal

Enter Nebraska DOC's transactions with Kayem Pharmaceuticals Private Limited, a small generic drug manufacturer based out of Marian Colony in Borivali, Mumbai. A series of emails, which The Hindu has in its possession, began between a representative of the Nebraska DOC and a Kayem sales representative in November 2010, the subject of discussion being the export of 500 one-gram vials of thiopental, valued at $2,056.15, from Mumbai to Nebraska.

The deal appeared to be progressing smoothly until the shipment reached Omaha around mid-December. A hold-up occurred at that point owing to the FDA's lack of clarity on whether or not the Nebraska DOC had a sufficient legal basis for importing the lethal drug. The FDA finally relented on January 7, 2011, making what informed observers described as a “political decision to not review the importation of the drugs.” It, however, clarified its position to the Nebraska DOC, saying: “In keeping with established practice, FDA does not review or approve products for the purpose of lethal injection. FDA has not reviewed the products in this shipment to determine their identity, safety, effectiveness, purity or any other characteristics.”

Yet with this action the FDA has risked unleashing an execution-frenzy among thiopental-starved death penalty States.

Already a likely victim of Indian-made thiopental has been identified — Carey Dean Moore (53). He awaits execution in the Nebraska DOC, now the owner of enough Kayem-manufactured thiopental to execute 166 men.

With the U.S.' patchy record of untested anaesthetics that fail to produce the expected unconsciousness, Moore may also expect the same outcome as Rhode, which Dr. Heath described thus: “There is no dispute that the asphyxiation caused by pancuronium [the second, paralytic agent administered] and the caustic burning sensation caused by potassium [the third, heart-stopping agent administered] would be agonising in the absence of adequate anaesthesia.”

Unless last week's seizures of Kentucky's and Tennessee's stocks of imported thiopental by the U.S. Drug Enforcement Agency are repeated in other States and the proliferation of these untested drugs eventually stopped, we could enter a new era of “cruel and unusual punishment” for death row inmates across the country. Already, it is possible that the dubious Indian barbiturate has found its way into the broader healthcare system and reached the DOCs of several States.

India's options

And for India, itself a user of capital punishment, although in the “rarest of rare” cases, it is anybody's guess as to whether authorities will follow the stellar example of the U.K. and Italy and ban the export of lethal drugs to the U.S. Perhaps in a stroke of irony it will be economics rather than morality that will stall the entry of Indian generic drug manufacturers into this bloodthirsty niche of global commerce.

According to Reprieve's Mr. Smith, “Kayem can expect to be party to U.S. litigation for decades. It may have made them a small profit at the start, but they will end up paying lawyers until their profits have vanished one hundred times.”

Indeed, even as Reprieve held a press conference in Mumbai this week to raise awareness of the issue in the country, Kayem announced: “In view of the sensitivity involved with sale of our Thiopental Sodium to various... prisons in USA and as alleged to be used for the purpose of lethal injection, we voluntary declare that we... refrain ourselves in selling this drug where the purpose is purely for lethal injection and its misuse.”

However, if the lethal drugs export persists, even as India clamours for a more prominent place on the world stage, it will have to hide the embarrassing fact that it tacitly condones its merchants of death.

Source: The Hindu, Opinion, Narayan Lakshman, March 8, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Thursday, April 7, 2011

Death Penalty Foes Shut Down Another Execution-Drug Supply Route

An Indian drug company that supplied thiopental sodium to U.S. prisons has decided to halt future sales following objections from death penalty opponents.

Kayem Pharmaceutical Pvt. Ltd supplied Nebraska prison officials with a large supply of thiopental sodium, an anesthetic typically used to render a condemned inmate unconscious before other lethal drugs, including a paralytic agent, are administered.

The company also supplied the drug to South Dakota, Navneet Verma, the managing director of the Mumbai-based company, told WSJ.

“We appreciate the global concerns about the death penalty and particularly the concerns of the human rights community,” Mr. Verma said. “I decided voluntarily not to sell a single vial of thiopental for use in lethal injections.” (Here’s a statement on Kayem’s website about the decision and here’s a WSJ article.)

The decision could make it even more difficult for U.S. prisons to find the drug, which has been in short supply for about a year. Prison officials in South Dakota and Nebraska were not immediately available for comment.

Hospira Inc., the only U.S. manufacturer of thiopental, decided earlier this year to stop making the drug due to concerns from death-penalty opponents.

Some states, including Texas, have switched from using thiopental to pentobarbital, a sedative often used to euthanize animals.

Source: Nathan Koppel, Law Blog, The Wall Street Journal, April 6, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Tuesday, April 5, 2011

US death row injection comes from Mumbai firm

MUMBAI: Correctional services in the US are buying sodium thiopental from a little-known firm in Borivli (West) for use in lethal injections to execute death sentences.

Kayem Pharmaceuticals Pvt Ltd, at Marian Colony, shipped a 500-gram consignment of the yellow powder, packed in a hefty 25-kg strongbox, on December 8, 2010, to the Nebraska department of correctional services. Sodium thiopental is generally used along with pancuronium bromide and potassium chloride to create a cocktail with which several states in the US carry out the death sentence by lethal injection. In February this year, Kayem sold another consignment to the South Dakota department of corrections. Executions are yet to be carried out by Nebraska or South Dakota with the drug purchased from Kayem.

Sodium thiopental has been in short supply in the US for about a year after the sole American company that manufactured it ceased production. That has forced American prisons to look abroad. For Nebraska and South Dakota, that search led to the residential Greenfield Cooperative Housing Society in Borivli (West), where Kayem is located. Kayem is a two-room set-up — office and storeroom — with a balcony that doubles as a kitchen.

American prisons have taken flak for purchasing sodium thiopental, used in lethal injections, from overseas. An earlier purchase from the UK apparently degraded by the time it reached American shores, said Clive Stafford Smith, director of Reprieve, an international charity assisting people around the world facing the death penalty. "The failure of the sodium thiopental purchased in the UK has thus far caused the excruciating and torturous death of three people, one in Arizona and two in Georgia," Smith said.

That prompted a lawyer in Nebraska — where the execution of Carey Dean Moore, 53, is pending — to move court there against the use of the sodium thiopental bought from Kayem. There were also questions raised about whether Kayem is properly registered in the US.

Officials in the Nebraska corrections department did not respond to queries emailed by this newspaper. However, replying to the court in the Nebraska case, state solicitor-general J Kirk Brown said: "The state of Nebraska has duly enacted a new statutory method of execution (lethal injection) and adopted an execution protocol pursuant to the statute, which together satisfy all currently understood requirements of our state and federal constitutions."

Kayem, a small-scale Indian company, may now be in a position to increase its business. "Several American states have now approached us for sodium thiopental," said Navneet Verma, director, Kayem Pharmaceuticals. Verma said he sold the first consignment of 500 grams to the Nebraska correctional services at $3.50 a gram. That works out to $1,750, or around Rs 78,000. When officials at the South Dakota department of corrections evinced interest to buy the same drug, Kayem jacked the price up to $10 a gram.

Derived by mixing sodium and thiopentone, the drug sodium thiopental doesn't really require a huge facility to manufacture and goes for around Rs 35 a gram in the Indian market.

Source: The Times of India, April 5, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Wednesday, March 16, 2011

Shortage Forces Texas To Switch Execution Drug

Holding cells and execution chamber
Huntsville Unit, Texas
Texas is changing one of the drugs used to conduct executions in the nation's busiest death penalty state due to a shortage of a sedative it's used for nearly three decades, officials said Wednesday.

Texas Department of Criminal Justice officials said they plan to substitute pentobarbital for sodium thiopental in the three-drug cocktail used for lethal injections. Pentobarbital, a surgical sedative, also is commonly used to euthanize animals and recently has been used for executions in Oklahoma.

A shortage of sodium thiopental has forced multiple states to scramble for substitutes. Texas has used the drug since becoming the first state to do lethal injections in 1982. Texas' supply of sodium thiopental expires at the end of this month and an execution is set for early April.

Agency spokeswoman Michelle Lyons said Rick Thaler, director of the agency's institutional division, authorized the switch.

"It's in the state statute that changes in chemical and dosages may be made at the discretion of the institutional division director," she said. "We were looking for a drug with similar properties to sodium thiopental and this drug has been used in the Oklahoma execution process so there is a precedent for its use in executions."

Pentobarbital use has survived court challenges in Oklahoma, which also uses it in conjunction with two other drugs that paralyze inmates and stop their hearts. Ohio recently switched to pentobarbital as the sole drug used for its executions.

Texas' prison director has the authority to tweak the state's execution process, like changing the drug, and only a switch from lethal injection to another form of capital punishment would require legislative action in Texas. Texas used the electric chair for executions from the 1920s until the 1960s.

Texas inmate Charlie Brooks became the first in the nation to be executed by injection on Dec. 7, 1982. Texas has since executed 466 people, far more than any other state. Seventeen inmates were put to death last year in Texas and two have been executed this year.

Convicted killer Cleve Foster, who is scheduled for execution on April 5, would be the first to be given the new drug in Texas. At least four other inmates are on the state's execution schedule for the coming months. Other drugs used in the process are pancuronium bromide and potassium chloride.

The sodium thiopental shortage has delayed executions in several states and an Associated Press review found that at least five states — Arizona, Arkansas, California, Georgia and Tennessee — had to turn to England for their supply of the drug. Nebraska, meanwhile, secured a stockpile from an Indian firm. On Tuesday, Drug Enforcement Administration agents seized Georgia's supply of the sedative, saying officials had questions about how the drug was imported.

Source: AP, March 16, 2011


Texan executioners turn to Danish manufacturer Lundbeck for experimental lethal injection drug

Danish pharmaceutical manufacturer Lundbeck is set to become the primary source of lethal injection drugs for Texas, the busiest executing state in the US, after the state changed its lethal injection procedure in response to a nationwide shortage of the anaesthetic sodium thiopental.

The Texas Department of Criminal Justice plans to replace thiopental with pentobarbital -- for which Lundbeck is the sole FDA-approved supplier in the USA.

Lundbeck’s response will determine the fate of scores of prisoners, not just in Texas, but across the US prison system. Texas is the leading death penalty state, and the third to change its protocol to pentobarbital, putting Lundbeck at serious risk of becoming the main go-to point for execution chambers throughout the country. Texas’s supply of sodium thiopental expires on the 31st March; the state has three executions already scheduled from April to July, for which it will be relying on Lundbeck’s Danish drugs to kill prisoners.

The use of pentobarbital in executions is experimental and considered highly dangerous because the drug, a sedative, was not designed to be used as an anaesthetic. According to Dr. David Waisel, Associate Professor of Anaesthesia at Harvard Medical School: “The use of pentobarbital as an agent to induce anesthesia has no clinical history and is non-standard… the combination of significant unknowns… puts the inmate at risk of serious undue pain and suffering.”

Texas’s decision to switch drugs comes after the US Drug Enforcement Administration seized Georgia's British-sourced sodium thiopental amid increasing fears that the drug has caused excruciating pain to prisoners.

The first prisoner likely to be killed with Lundbeck drugs, Cleve Foster, was sentenced to death for a 2002 murder, despite the fact that another man had confessed to the crime. Cleve is facing execution in Texas on 5th April.

Reprieve's Director Clive Stafford Smith said: "This is the moment of truth for Lundbeck. As a supposedly ethical company, will it baulk at profiting from the killing of prisoners?”

Source: Reprieve, March 16, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Saturday, February 19, 2011

Nebraska Prison officials respond to lawmakers' request for information on lethal injection drug

The state Department of Correctional Services has responded to a letter from 3 state senators asking for details about the department's recent purchase from an Indian company of one of the drugs used in Nebraska's lethal-injection protocol.

The department recently bought such a large quantity of a drug used to kill death-row inmates that it now has enough to carry out 166 executions -- even though it has just 12 men on death row.

The state paid $2,056 to Kayem Pharmaceutical Pvt. Ltd. for 500 grams of sodium thiopental, the minimum purchase required by the company, according to corrections officials.

Sens. Danielle Conrad of Lincoln and Brenda Council and Jeremy Nordquist of Omaha sent the letter Feb. 3 to Bob Houston, director of the department.

The letter asked for, among other things, documentation regarding how the drug was imported into the United States, how the drug was tested, the results of those tests, the chain of custody for the drug while en route to Nebraska and whether the department solicited bids for the drug.

Conrad said the three lawmakers wanted to make sure the Legislature maintains a role in ensuring "constitutional and statutory rules and regulations are adhered to.

"This is really ensuring that the Legislature takes an appropriate oversight role on these issues as we move forward ... rather than washing our hands and saying 'They'll just work it out,'" Conrad said. "We need to have clear, concrete facts and specifics on these issues."

According to the documents, the department paid Phil Patterson Inc., an import company based in Omaha, to facilitate shipment of the drug from India.

Kayem issued a certificate of origin for the drug and the shipment was under the supervision of customs officials in India and the United States, said Megan Cooley, who oversaw the importation for Phil Patterson Inc.

Once the shipment arrived in the United States, it was tested by Medtox Laboratories in St. Paul, Minn., to verify that it was sodium thiopental, according to the documents.

There has been a shortage of the drug, which is said to cause unconsciousness in less than a minute, since last year. And the only U.S. manufacturer of the drug, Hospira Inc., said it is ending production because of death-penalty opposition overseas.

Mark Caverly of the U.S. Drug Enforcement Administration said states can give or sell doses of the drug to other states for use in executions, as long as they are both registered with the DEA and the drug was properly imported.

A doctor, hospital, clinic or, in this case, the corrections department, can transfer up to 5 percent of the total controlled substances it buys in a year to another DEA-registered entity.

But Nebraska prison officials are not looking at doing so, even though the expiration date for the batch Nebraska got is August 2012. They have declined to say why.

The Nebraska lethal injection protocol uses a 3-gram dose of sodium thiopental followed by a consciousness check one minute later. If the inmate is not unconscious, another 3 grams are given.

Nebraska's protocol then calls for 2 more drugs to be given: pancuronium bromide, a paralyzing agent, and then potassium chloride to stop the heart.

Sodium thiopental is a barbiturate that has been used to anesthetize patients for surgery and induce medical comas. It also has been used to help terminally ill people commit suicide.

A federal lawsuit has been filed in Arizona challenging the use of the drugs from overseas suppliers, saying they may be substandard and could lead to problems during executions.

The Nebraska Legislature approved lethal injection as the state's method of execution in May 2009. The state has not executed an inmate since Robert Williams died in the electric chair in 1997.

Critics of lethal injection have argued that corrections workers who don't regularly administer intravenous drugs may have trouble finding a vein. Supporters say training requirements spelled out in the protocol -- including that members of the IV teams be trained as emergency medical technicians -- alleviate that concern.

Shortly after Nebraska got its sodium thiopental, state officials asked the Nebraska Supreme Court to set an execution date for Carey Dean Moore, who has been on death row since 1980.

Moore, 53, was sentenced to death for killing Omaha cab drivers Maynard D. Helgeland and Reuel Eugene Van Ness during botched robberies in 1979.

Source: Journal Star, February 18, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Thursday, January 27, 2011

Nebraska considers 1st execution since 1997

If inmate Carey Dean Moore is put to death, it would be Nebraska's 1st execution since 1997 and its first lethal injection.

Attorney General Jon Bruning said a motion was filed with the Nebraska Supreme Court on Monday, requesting that a date be set. Moore was sentenced to death for the 1979 murders of 2 Omaha cabbies.

The state's last execution occurred in 1997, when Robert Williams was electrocuted for killing three women. 11 men remain on Nebraska's death row. Besides Williams, Harold Otey and John Joubert also have been electrocuted since the state resumed executions in 1994.

Moore's attorney, Alan Peterson, did not immediately respond to a message Tuesday. Moore was convicted of 1st-degree murder for killing taxi drivers Maynard D. Helgeland and Reuel Eugene Van Ness in botched robberies.

Moore, 53, came within a week of being executed in 2007, but 6 days before his scheduled execution the state's high court issued a stay because it wanted to consider whether the electric chair should still be used.

Then the Nebraska Supreme Court ruled in 2008 that the electric chair amounted to cruel and unusual punishment. Since then, lawmakers approved lethal injection as the state's sole method.

For nearly 4 decades, former state Sen. Ernie Chambers, who opposed the death penalty, held up any effort to change Nebraska's method of execution because he believed the electric chair eventually would be banished by the courts. Chambers' departure from the Legislature in 2008 because of term limits made it possible for lawmakers to pass the lethal injection bill.

On Friday, the state received the 3rd drug needed to carry out an execution by lethal injection. A worldwide shortage of the drug, sodium thiopental, has made it hard to acquire, and the only U.S. manufacturer of the drug announced last week that it would stop making it.

Nebraska's lethal-injection law and the execution procedure prison officials developed were modeled on Kentucky's system because that state's death penalty withstood the scrutiny of the U.S. Supreme Court in 2008.

The Nebraska Department of Correctional Services said last summer that it had prepared a new execution chamber and trained workers to carry out the death penalty once the state obtained the sodium thiopental that will be used to render an inmate unconscious. The other drugs involved in the process are pancuronium bromide, which paralyzes an inmate's breathing, and potassium chloride, which stops the heart.

Nebraska's 5-page lethal injection protocol requires that 3 drugs be administered during an execution by trained corrections workers, including 2 emergency technicians who would be responsible for maintaining an open IV line.

After an execution date is set, members of the execution team who have already received training will undergo weekly refresher courses. When no execution dates are scheduled, the team trains every 6 months.

Critics of lethal injection have argued that corrections workers who don't regularly administer intravenous drugs may have trouble finding a vein. Supporters say the training requirements spelled out in the protocol - including that members of the IV teams be trained as emergency medical technicians - would alleviate that concern.

All 36 death penalty states use lethal injection, and 35 rely on the 3-drug method. But the 3-drug procedure has been questioned.

In 2009, Ohio switched to a 1-drug execution procedure after the state botched a lethal injection. Romell Broom's executioners tried unsuccessfully for 2 hours to find a usable vein for injection, painfully hitting bone and muscle in as many as 18 needle sticks before the governor halted the execution.

It was not immediately clear Tuesday how soon the Supreme Court might set an execution date for Moore.

But legal challenges to Nebraska's new execution method could still put capital punishment on hold for several years in the state.

Attorneys who oppose the death penalty have said they expect lawsuits will be filed attacking various components of the new lethal injection protocol, including training requirements they say are vague. The law is also expected to be challenged under federal civil-rights law.

Source: Associated Press, January 26, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Wednesday, January 26, 2011

Ohio to Use Veterinary Drug in Lethal Injections

(AP) COLUMBUS, Ohio - The state is switching its sole lethal injection drug to one commonly used to put animals to sleep as a shortage of the drug normally used for executions has worsened, the Ohio Department of Rehabilitation and Correction announced Tuesday.

Beginning in March, the state execution team will use a single, powerful dose of pentobarbital, a common anesthetic used in surgeries and also by veterinarians to euthanize pets. The drug replaces sodium thiopental, which was already scarce when its only U.S. manufacturer announced last week it would no longer produce it.

Ohio is following the lead of Oklahoma, which switched to pentobarbital last year and has since used it three times. However, Ohio, which uses only a single dose of anesthetic to execute inmates, would become the first state to use pentobarbital alone, without two additional drugs that paralyze inmates and stop their hearts.

The prisons department said it will use its remaining supply of sodium thiopental for the scheduled execution Feb. 17 of Frank Spisak, who killed three people at Cleveland State University in 1982.

The first use of pentobarbital is planned for March's scheduled execution of Johnnie Baston of Lucas County, condemned to die for shooting the owner of a Toledo store in the back of the head during a 1994 robbery.

The switch was not unexpected. Ohio has said for weeks that while it had enough sodium thiopental for the Spisak execution, it would not comment about its supply beyond that.

The state nearly ran out of the drug last spring and almost had to postpone an execution before obtaining some at the last moment.

Ohio has no more executions currently scheduled, but prosecutors have asked the Ohio Supreme Court to set additional dates for 14 men whose appeals are concluded.

States across the country have scrambled to find supplies of sodium thiopental after Hospira Inc., of Lake Forest, Ill., the drug's lone U.S. manufacturer, stopped producing it more than a year ago.

Hospira, which produced it for medical purposes and not for executions, announced Friday it would not resume production after authorities in Italy refused to allow its production if the company couldn't guarantee it would not be used for capital punishment.

Hospira said its plant in Italy was the only viable facility where it could be manufactured.

Arizona, Arkansas, California and Tennessee are among states that found a supply of sodium thiopental in England, but that source dried up after the British government banned the drug's export for use in executions.

Earlier this month, Nebraska announced it had obtained 500 grams from a company in India.

Source: AP, January 25, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.

Sunday, January 23, 2011

Nebraska gets drug it needs to do lethal injections

The Nebraska Department of Corrections said Friday it has received a shipment of the last of 3 drugs needed to carry out death penalty executions.

The department got the supply of sodium thiopental, used to cause unconsciousness, on Jan. 7 from a pharmaceuticals company in India. A sample of the drug was tested by an independent U.S. laboratory and confirmed to be the correct drug, the department said.

Corrections Director Robert Houston said that, with the drug, the department is ready to carry out an execution if called upon to do so.

The drug, which is said to cause unconsciousness in less than a minute, has been difficult to obtain because of a shortage since at least last spring. The difficulty in obtaining the drug has disrupted executions around the country.

The Nebraska lethal injection protocol uses a 3-gram dose of sodium thiopental followed by a consciousness check one minute after administering it. If the inmate is not unconscious, another 3 grams are given.

2 drugs then are given after the inmate is confirmed to be unconscious: pancuronium bromide, a paralyzing agent, and then potassium chloride to stop the heart.

The department received 500 grams of the drug at a cost of $2,056. The drug received by the department expires in August 2012.

A federal lawsuit was filed in Arizona challenging the use of drugs from overseas suppliers, saying they may be substandard and could lead to problems during executions.

Nebraska approved lethal injection as its method of execution in 2009. The state hasn't executed an inmate since 1997. There are 11 men on death row, but there is no set execution date at this time for any of those inmates.

Source: Journal Star, January 22, 2011
_________________________
Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.